These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15345894)

  • 41. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
    Wu D; Thomas A; Fromm JR
    Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hodgkin's disease - a 'B' neoplasm?
    Staples WG; Visser AE
    S Afr Med J; 1978 Jul; 54(5):186-8. PubMed ID: 309183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cutaneous Hodgkin's disease: an immunohistochemical analysis.
    Cerroni L; Beham-Schmid C; Kerl H
    J Cutan Pathol; 1995 Jun; 22(3):229-35. PubMed ID: 7593816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD40 Ligand--an anti-apoptotic molecule in Hodgkin's disease.
    Metkar SS; Manna PP; Anand M; Naresh KN; Advani SH; Nadkarni JJ
    Cancer Biother Radiopharm; 2001 Feb; 16(1):85-92. PubMed ID: 11279801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunologic characterization of Reed-Sternberg cells and other cell components in lymph nodes with Hodgkin's disease.
    Watanabe S; Shimosato Y; Sato Y; Shimoyama M; Tobinai K; Mikata A
    Acta Pathol Jpn; 1984 Mar; 34(2):241-50. PubMed ID: 6377817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
    Knowles DM; Halper JP; Jakobiec FA
    Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain.
    Stein H; Hansmann ML; Lennert K; Brandtzaeg P; Gatter KC; Mason DY
    Am J Clin Pathol; 1986 Sep; 86(3):292-7. PubMed ID: 3529924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Feline Hodgkin's-like lymphoma: 20 cases (1992-1999).
    Walton RM; Hendrick MJ
    Vet Pathol; 2001 Sep; 38(5):504-11. PubMed ID: 11572557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. B- and T-lymphocytes in Hodgkin's disease. An immunohistochemical study utilizing heterologous and monoclonal antibodies.
    Forni M; Hofman FM; Parker JW; Lukes RJ; Taylor CR
    Cancer; 1985 Feb; 55(4):728-37. PubMed ID: 3155642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relationship between lymphocyte immunophenotypes and histologic subtypes of Hodgkin's lymphoma and its significance].
    Zhang Y; Li XZ; Wen ZH; Chen XY; Zhang G; Wang X; Wu ZQ; Zhao T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):888-93. PubMed ID: 19698223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between eosinophil density and T-cell activation markers in lymph nodes of patients with Hodgkin's disease.
    Ben-Ezra J; Sheibani K; Swartz W; Stroup R; Traweek ST; Kezirian J; Rappaport H
    Hum Pathol; 1989 Dec; 20(12):1181-5. PubMed ID: 2591947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hodgkin's disease and non-Hodgkin's lymphoma containing Reed-Sternberg-like giant cells in Taiwan. A clinicopathologic analysis of 50 cases.
    Hong RL; Su IJ; Chen YC; Hsieh HC; Wang CH; Liu CH; Shen MC
    Cancer; 1992 Mar; 69(5):1254-8. PubMed ID: 1739924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age-related loss of naïve T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes.
    Lazuardi L; Jenewein B; Wolf AM; Pfister G; Tzankov A; Grubeck-Loebenstein B
    Immunology; 2005 Jan; 114(1):37-43. PubMed ID: 15606793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The diversity of the immunohistological staining pattern of Sternberg-Reed cells.
    Poppema S
    J Histochem Cytochem; 1980 Aug; 28(8):788-91. PubMed ID: 6777426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease.
    Carbone A; Gloghini A; Aldinucci D; Gattei V; Dalla-Favera R; Gaidano G
    Br J Haematol; 2002 May; 117(2):366-72. PubMed ID: 11972519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concurrent Hodgkin's disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia/prolymphocytic leukemia.
    Miyata A; Kojima K; Yoshino T; Fujii S; Shinagawa K; Ichimura K
    Int J Hematol; 2001 Feb; 73(2):230-5. PubMed ID: 11372737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytologic criteria for subclassification of Hodgkin's disease using fine-needle aspiration.
    Moriarty AT; Banks ER; Bloch T
    Diagn Cytopathol; 1989; 5(2):122-5. PubMed ID: 2776595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical detection of cells positive for colony-stimulating factor 1 in lymph nodes from reactive lymphadenitis, and Hodgkin's disease.
    Moreau A; Praloran V; Berrada L; Coupey L; Gaillard F
    Leukemia; 1992 Feb; 6(2):126-30. PubMed ID: 1552743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategies for immunophenotyping and purifying classical Hodgkin lymphoma cells from lymph nodes by flow cytometry and flow cytometric cell sorting.
    Fromm JR; Wood BL
    Methods; 2012 Jul; 57(3):368-75. PubMed ID: 22487184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of A and B-type lamin expression in reactive lymph nodes and nodular sclerosing Hodgkin's disease.
    Jansen MP; Machiels BM; Hopman AH; Broers JL; Bot FJ; Arends JW; Ramaekers FC; Schouten HC
    Histopathology; 1997 Oct; 31(4):304-12. PubMed ID: 9363444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.